Showing results (241-250 of 281) with videos related to
Sort By:
Pageof 29
Casopis Lekaru Ceskych|January 8, 1997
[Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?]J Jelínek, L J Fairbairn, T M Dexter, et al.Anti-Cancer Drugs|October 1, 1994
Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-onesJ A Hadfield, V H Pavlidis, A T McGown, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pumpM Hrubisko, A T Mc Gown, J A Prendiville, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patientsJ P Stewart, A T McGown, J Prendiville, et al.Behring Institute Mitteilungen|August 1, 1988
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerM Bronchud, J H Scarffe, N Thatcher, et al.Gene Therapy|September 25, 1998
Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitroI Hickson, L J Fairbairn, N Chinnasamy, et al.British Journal of Haematology|September 21, 2000
A transient assay for regulatory gene function in haemopoietic progenitor cellsZ J McIvor, C M Heyworth, B A Johnson, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
Interleukin-3-dependent hematopoietic stem cell lines capable of osteoclast formation in vitroC E Hagenaars, E W Kawilarang-de Haas, A A van der Kraan, et al.Ciba Foundation Symposium|January 1, 1990
Stromal cells in haemopoiesisT M Dexter, L H Coutinho, E Spooncer, et al.British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.Pageof 29